Literature DB >> 20207742

Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.

Ichiaki Ito1, Aki Hanyu, Mitsutoshi Wayama, Natsuka Goto, Yoko Katsuno, Shohei Kawasaki, Yuka Nakajima, Masashi Kajiro, Yoko Komatsu, Akiko Fujimura, Ryuichi Hirota, Akiko Murayama, Keiji Kimura, Takeshi Imamura, Junn Yanagisawa.   

Abstract

Estrogen is a growth factor that stimulates cell proliferation. The effects of estrogen are mediated through the estrogen receptors, ERalpha and ERbeta, which function as ligand-induced transcription factors and belong to the nuclear receptor superfamily. On the other hand, TGF-beta acts as a cell growth inhibitor, and its signaling is transduced by Smads. Although a number of studies have been made on the cross-talk between estrogen/ERalpha and TGF-beta/Smad signaling, whose molecular mechanisms remain to be determined. Here, we show that ERalpha inhibits TGF-beta signaling by decreasing Smad protein levels. ERalpha-mediated reductions in Smad levels did not require the DNA binding ability of ERalpha, implying that ERalpha opposes the effects of TGF-beta via a novel non-genomic mechanism. Our analysis revealed that ERalpha formed a protein complex with Smad and the ubiquitin ligase Smurf, and enhanced Smad ubiquitination and subsequent degradation in an estrogen-dependent manner. Our observations provide new insight into the molecular mechanisms governing the non-genomic functions of ERalpha.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207742      PMCID: PMC2863224          DOI: 10.1074/jbc.M109.093039

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase.

Authors:  Y Zhang; C Chang; D J Gehling; A Hemmati-Brivanlou; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Combinatorial control of gene expression by nuclear receptors and coregulators.

Authors:  Neil J McKenna; Bert W O'Malley
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

3.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.

Authors:  P Kavsak; R K Rasmussen; C G Causing; S Bonni; H Zhu; G H Thomsen; J L Wrana
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

4.  Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.

Authors:  T Ebisawa; M Fukuchi; G Murakami; T Chiba; K Tanaka; T Imamura; K Miyazono
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

5.  Cross-talk between bone morphogenic proteins and estrogen receptor signaling.

Authors:  Tetsuya Yamamoto; Fahri Saatcioglu; Tadashi Matsuda
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

6.  Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3.

Authors:  T Matsuda; T Yamamoto; A Muraguchi; F Saatcioglu
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

7.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

8.  Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.

Authors:  George Reid; Michael R Hübner; Raphaël Métivier; Heike Brand; Stefanie Denger; Dominique Manu; Joël Beaudouin; Jan Ellenberg; Frank Gannon
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

9.  The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

Authors:  D M Lonard; Z Nawaz; C L Smith; B W O'Malley
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

10.  Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.

Authors:  Yongsheng Ren; Liyu Wu; Andra R Frost; William Grizzle; Xu Cao; Mei Wan
Journal:  Mol Cancer       Date:  2009-11-27       Impact factor: 27.401

View more
  64 in total

1.  Estrogen inhibits vaginal tropoelastin and TGF-β1 production.

Authors:  Nahida Chakhtoura; Yanping Zhang; Keith Candiotti; Carlos A Medina; Peter Takacs
Journal:  Int Urogynecol J       Date:  2012-06-06       Impact factor: 2.894

2.  dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks.

Authors:  Peilin Jia; Siyuan Zheng; Jirong Long; Wei Zheng; Zhongming Zhao
Journal:  Bioinformatics       Date:  2010-11-02       Impact factor: 6.937

3.  Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.

Authors:  Yong-Hun Lee; William P Schiemann
Journal:  Breast Cancer Manag       Date:  2014

4.  Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats.

Authors:  Minji Choi; Harmesh N Chaudhari; Young Rae Ji; Zae Young Ryoo; Sang Woo Kim; Jong Won Yun
Journal:  Mol Cell Biochem       Date:  2015-06-06       Impact factor: 3.396

5.  Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine.

Authors:  Wendy A Goodman; Sarah M Bedoyan; Hannah L Havran; Brian Richardson; Mark J Cameron; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 11.205

Review 6.  Effects of psoralens as anti-tumoral agents in breast cancer cells.

Authors:  Maria Luisa Panno; Francesca Giordano
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  E3 ubiquitin ligases in regulating stress fiber, lamellipodium, and focal adhesion dynamics.

Authors:  Shishan Deng; Cai Huang
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

8.  Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.

Authors:  M L Panno; F Giordano; P Rizza; M Pellegrino; D Zito; C Giordano; L Mauro; S Catalano; S Aquila; D Sisci; F De Amicis; A Vivacqua; S W A Fuqua; S Andò
Journal:  Breast Cancer Res Treat       Date:  2012-10-09       Impact factor: 4.872

Review 9.  Role of Smad signaling in kidney disease.

Authors:  Yanhua Zhang; Songyan Wang; Shengmao Liu; Chunguang Li; Ji Wang
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

10.  Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues.

Authors:  D S Lang; S Marwitz; U Heilenkötter; W Schumm; O Behrens; R Simon; M Reck; E Vollmer; T Goldmann
Journal:  Pathol Oncol Res       Date:  2014-03-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.